Hostname: page-component-5c6d5d7d68-thh2z Total loading time: 0 Render date: 2024-08-16T09:15:59.397Z Has data issue: false hasContentIssue false
  • English
  • Français

Vulnerability in Clinical Research with Patients in Pain: A Risk Analysis

Published online by Cambridge University Press:  01 January 2021

Raymond C. Tait
Get access Rights & Permissions [Opens in a new window]

Extract

The concept of vulnerability has been the topic of considerable discussion in research bioethics, largely because of dissatisfaction with early constructions of the concept that were based on subpopulations of research subjects. These subpopulations have attributes likely to undermine their capacity to provide autonomous informed consent: persons who are relatively or absolutely incapable of protecting their own interests through negotiations for informed consent. Several subpopulations were seen as requiring special protections, including children, pregnant women, prisoners, racial minorities, the economically disadvantaged, the very sick, and the institutionalized. Recent years have witnessed the identification of other subpopulations with attributes that could render them vulnerable, as well. For example, the Council for the International Organization of Medical Societies has named such potentially vulnerable groups as the homeless, nursing home residents, patients with incurable diseases, patients in the emergency department, employees, students, and members of communities who are unfamiliar with modern medicine.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 37 , Issue 1 , Spring 2009 , pp. 59 - 72
Copyright
Copyright © American Society of Law, Medicine and Ethics 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Guidelines for the Protection of Human Subjects of Research (Washington, D.C.: U.S. Government Printing Office, 1979): at 8.Google Scholar
Council for International Organization of Medical Societies, International Ethical Guidelines for Biomedical Research involving Human Subjects, Commentary on Guideline 13, 2002, available at <www.cioms.ch> (last visited July 15, 2008).+(last+visited+July+15,+2008).>Google Scholar
DeBruin, D., “Reflections on “Vulnerability,” Bioethics Examiner 5, no. 3 (2001): 1–7; Levine, C. Faden, R. Grady, C. Hammerschmidt, D. Eckenwiler, L. Sugarman, J., “The Limitations of ‘Vulnerability’ as a Protection for Human Research Subjects,” American Journal of Bioethics 4, no. 3 (2004): 44–49.Google Scholar
Grinnell, F., “Subject Vulnerability: The Precautionary Principle of Human Research,” American Journal of Bioethics 4, no. 3 (2004): 72–74; see Levine, , supra note 3.CrossRefGoogle Scholar
Kottow, M. H., “The Vulnerable and the Susceptible,” Bioethics 17, nos. 5–6 (2003): 460–471; see also Levine, , supra note 3.CrossRefGoogle Scholar
Schweitzer, A., On the Edge of the Primeval Forest (New York: Macmillan, 1931): at 2.Google Scholar
Blacksher, E., “Hearing from Pain: Using Ethics to Reframe, Prevent, and Resolve the Problem of Unrelieved Pain,” Pain Medicine 2, no. 2 (2001): 169–175.CrossRefGoogle Scholar
Brennan, F. Carr, D. B. Cousins, M., “Pain Management: A Fundamental Right,” Anesthesia & Analgesia 105, no. 1 (2007): 205–221.CrossRefGoogle Scholar
VanderWalde, A. M., “Vulnerability as the Inability of Researchers to Act in the Best Interest of a Subject,” American Journal of Bioethics 4, no. 3 (2004): 65–66.CrossRefGoogle Scholar
Henderson, G. E. Davis, A. M. King, N. M. P., “Vulnerability to Influence: A Two-Way Street,” American Journal of Bioethics 4, no. 3 (2004): 50–52.CrossRefGoogle Scholar
Shivas, T., “Contextualizing the Vulnerability Standard,” American Journal of Bioethics 4, no. 3 (2004): 84–86.CrossRefGoogle Scholar
Marshall, M. F., “Vulnerable Subjects and Civic Professionalism: Would Six-Sigma Research and Research Ethics Consultation Solve the Vulnerability Problem?” American Journal of Bioethics 4, no. 3 (2004): 54–55.CrossRefGoogle Scholar
Vawter, D. E. Gervais, K. G. Freeman, T. B., “Strategies for Achieving High-Quality IRB Review,” American Journal of Bioethics 4, no. 3 (2004): 74–76.CrossRefGoogle Scholar
Campbell, A. T., “‘Vulnerability’ in Context: Recognizing the Sociopolitical Influences,” American Journal of Bioethics 4, no. 3 (2004): 58–59.CrossRefGoogle Scholar
Healy, D. Cattel, D., “Interface between Authorship, Industry and Science in the Domain of Therapeutics,” British Journal of Psychiatry 183, nos. 3–4 (2003): 22–27; Psaty, B. M. Kronmal, R. A., “Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment,” JAMA 299, no. 15 (2008): 1813–1817.CrossRefGoogle Scholar
Lemmens, T. Miller, P. B., “The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives,” Journal of Law, Medicine & Ethics 31, no. 3 (2003): 398–418.CrossRefGoogle Scholar
DeAngelis, C. D. Fontanarosa, P. B., “Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence,” JAMA 299, no. 15 (2008): 1833–1835; Ross, J. S. Hill, K. P. Egilman, D. S. Krumholz, H. M., “Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation,” JAMA 299, no. 15 (2008): 1800–1812.CrossRefGoogle Scholar
DeBruin, D. A., “Looking Beyond the Limitations of ‘Vulnerability’: Reforming Safeguards in Research,” American Journal of Bioethics 4, no. 3 (2004): 76–78.CrossRefGoogle Scholar
See DeBruin, , supra note 3, at 7.Google Scholar
Merskey, H. Bogduk, N., Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed. (Seattle: IASP Press, 1994): at 210.Google Scholar
Turk, D. C. Melzack, R., “The Measurement of Pain and the Assessment of People Experiencing Pain,” in Turk, D. C. Melzack, R., eds., Handbook of Pain Assessment, 2nd ed. (New York: The Guilford Press, 2001): at 3.Google Scholar
Jensen, R. Tfelt-Hansen, P., “Headache,” in Jensen, T. S. Wilson, P. R. Rice, A. S. C., eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): at 467.Google Scholar
Campbell, F. A. Atcheson, R., “Chronic Back Pain,” in Jensen, T. S. Wilson, P. R. Rice, A. S. C., eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): at 524.Google Scholar
Turner, J. A. LeResche, L. Von Korff, M. Ehrlich, K., “Back Pain in Primary Care: Patient Characteristics, Content of Initial Visit, and Short-Term Outcomes,” Spine 23, no. 4 (1998): 463–469; Turner, J. A. Franklin, G. Turk, D. C., “Predictors of Chronic Disability in Injured Workers: A Systematic Literature Synthesis,” American Journal of Industrial Medicine 38, no. 6 (2000): 707–722; Gatchel, R. J. Dersh, J., “Psychological Disorders and Chronic Pain: Are There Cause- and-Effect Relationships?” in Turk, D. C. Gatchel, R. J., eds., Psychological Approaches to Pain Management: A Practitioner's Handbook, 2nd ed. (London: The Guilford Press, 2002): at 33.Google Scholar
Merskey, H. Teasell, R. W., “The Disparagement of Pain: Social Influences on Medical Thinking,” Pain Research and Management 5, no. 4 (2000): 259–270.CrossRefGoogle Scholar
Agrawal, M. Emanuel, E. J., “Ethics of Phase 1 Oncology Studies: Reexamining the Arguments and Data,” JAMA 290, no. 8 (2003): 1075–1082; Cantor, N. L. Thomas, G. C., “Pain Relief, Acceleration of Death, and Criminal Law,” Kennedy Institute of Ethics Journal 6, no. 2 (1996): 107–128; Emanuel, E. J., “Pain and Symptom Control: Patient Rights and Physician Responsibilities,” Hematology/Oncology Clinics of North America 10, no. 1 (1996): 41–56; Emanuel, E. J., “Attending to Psychologic Symptoms and Palliative Care,” Journal of Clinical Oncology 20 (2002): 624–626; Pellegrino, E. D., “Emerging Ethical Issues in Palliative Care,” JAMA 279, no. 19 (1998): 1521–1522.CrossRefGoogle Scholar
Hadler, N. M., “MRI for Regional Back Pain: Need for Less Imaging, Better Understanding,” JAMA 289, no. 21 (2003): 2863–2865; Rudy, T. E. Turk, D. C. Brena, S. F., “Differential Utility of Medical Procedures in the Assessment of Chronic Pain Patients,” Pain 34, no. 1 (1988): 53–60.CrossRefGoogle Scholar
Chibnall, J. T. Tait, R. C. Ross, L. R., “The Effects of Medical Evidence and Pain Intensity on Medical Student Judgments of Chronic Pain Patients,” Journal of Behavioral Medicine 20, no. 3 (1997): 257–271; Grossman, S. A. Sheidler, V. R. Swedeen, K. Mucenski, J. Piantadosi, S., “Correlation of Patient and Caregiver Ratings of Cancer Pain,” Journal of Pain and Symptom Management 6, no. 2 (1991): 53–57.CrossRefGoogle Scholar
Tait, R. C. Chibnall, J. T. Kalauokalani, D. A., “Provider Judgments of Patients in Pain: Seeking Symptom Certainty,” Pain Medicine (in press).Google Scholar
Fiske, S. T. Taylor, S. E., Social Cognition, 2nd ed. (New York: McGraw-Hill, 1991): at 14.Google Scholar
See Brennan, , supra note 8; Cassell, E. J., “The Nature of Suffering and the Goals of Medicine,” New England Journal of Medicine 306, no. 11 (1982): 639–645; Rich, B. A., “A Legacy of Silence: Bioethics and the Culture of Pain,” Journal of Medical Humanities 18, no. 4 (1997): 233–259; Johnson, S. H., “Legal and Ethical Perspectives on Pain Management,” Anesthesia & Analgesia 105, no. 1 (2007): 5–7; Merskey, Teasell, , supra note 25.Google Scholar
Tait, R. C., “The Social Context of Pain Management,” Pain Medicine 8, no. 1 (2007): 1–2.CrossRefGoogle Scholar
Blacksher, E., “Hearing from Pain: Using Ethics to Reframe, Prevent, and Resolve the Problem of Unrelieved Pain,” Pain Medicine 2, no. 2 (2001): 169–175, at 170.CrossRefGoogle Scholar
Appelbaum, P. S. Lidz, C. W. Grisso, T., “Therapeutic Misconception in Clinical Research: Frequency and Risk Factors,” IRB: Ethics & Human Research 26, no. 2 (2004): 1–8, at 1.CrossRefGoogle Scholar
Id.Google Scholar
Fleming, S. Rabago, D. P. Mundt, M. P. Fleming, M. F., “CAM Therapies among Primary Care Patients Using Opioid Therapy for Chronic Pain,” BMC Complementary and Alternative Medicine 7, no. 15 (2007): 15–22, available at <http://www.biomedcentral.com/1472–6882> (last visited July 15, 2008); Upchurch, D. M. Chyu, L. Greendale, G. A. Utts, J. Bair, Y. A. Zhang, G. Gold, E. B., “Complementary and Alternative Medicine Use among American Women: Findings from the National Health Interview Survey, 2002,” Journal of Women's Health 16, no. 1 (2007): 102–113.CrossRefGoogle Scholar
Werner, A. Malterud, K., “It Is Hard Work Behaving as a Credible Patient: Encounters between Women with Chronic Pain and Their Doctors,” Social Science & Medicine 57, no. 8 (2003): 1409–1419.CrossRefGoogle Scholar
Camarda, C. Monastero, R. Pipia, C. Reca, D. Camarda, R., “Interictal Executive Dysfunction in Migraineurs without Aura: Relationship with Duration and Intensity of Attacks,” Cephalalgia 27, no. 10 (2007): 1094–1100; Dick, B. D. Rashiq, S., “Disruption of Attention and Working Memory Traces in Individuals with Chronic Pain,” Anesthesia & Analgesia 104, no. 5 (2007): 1223–1239.CrossRefGoogle Scholar
Dick, B. D. Eccleston, C. Crombez, G., “Attentional Functioning in Fibromyalgia, Rheumatoid Arthritis, and Musculoskeletal Pain Patients,” Arthritis & Rheumatism 47, no. 6 (2002): 639–644.CrossRefGoogle Scholar
Bayer, A. Fish, M., “The Doctor's Duty to the Elderly Patient in Clinical Trials,” Drugs & Aging 20, no. 15 (2003): 1087–1097; Dick, B., “Fitness of Patients in Pain to Make Optimal Decisions,” Anesthesia & Analgesia 106, no. 2 (2008): 669–670.CrossRefGoogle Scholar
Kim, S. Y. H. Caine, E. D. Currier, G. W. Leibovici, A. Ryan, J. M., “Assessing the Competence of Persons with Alzheimer's Disease in Providing Informed Consent for Participation in Research,” American Journal of Psychiatry 158, no. 5 (2001): 712–717; Raymont, V. Bingley, W. Buchanan, A. David, A. S. Hayward, P. Wessely, S. Hotopf, M., “Prevalence of Mental Incapacity in Medical Inpatients and Associated Risk Factors: Cross-sectional Study,” The Lancet 364, no. 9443 (2004): 1421–1427.CrossRefGoogle Scholar
See Gatchel, Dersh, , supra note 24; Sullivan, M. D., “Assessment of Psychiatric Disorders,” in Turk, D. C. Melzack, R., eds., Handbook of Pain Assessment, 2nd ed. (New York: The Guilford Press, 2001): 275–291, at 275.Google Scholar
Dresser, J. D., “Research Involving Persons with Mental Disabilities: A Review of Policy Issues and Proposals,” in National Bioethics Advisory Commission, Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity: Commissioned Papers, 1999, at 5–28.Google Scholar
Appelbaum, P. S. Grisso, T. Frank, E. O'Donnell, S. Kupfer, D. J., “Competence of Depressed Patients for Consent to Research,” American Journal of Psychiatry 156, no. 9 (1999): 1380–1384.Google Scholar
Roberts, L. W., “Ethics and Mental Illness Research,” Psychiatric Clinics of North America 25, no. 3 (2002): 525–545.CrossRefGoogle Scholar
Chen, D. T. Miller, F. G. Rosenstein, D. L., “Enrolling Decisionally Impaired Adults in Clinical Research,” Medical Care 40, Supplement 9 (2002): V20–V29; Wirshing, D. A. Wirshing, W. C. Marder, S. R. Liberman, R. P. Mintz, J., “Informed Consent: Assessment of Comprehension,” American Journal of Psychiatry 155, no. 9, Supplement (1998): 1508–1511.CrossRefGoogle Scholar
See Turner, (1998), supra note 24.Google Scholar
Deshields, T. L. Tait, R. C. Gfeller, J. Chibnall, J. T., “The Influence of Social Desirability on Self-Report in Chronic Pain Patients,” Clinical Journal of Pain 11, no. 3 (1995): 189–193.CrossRefGoogle Scholar
Williams, D. A. Park, K. M. Ambrose, K. R. Clauw, D. J., “Assessor Status Influences Pain Recall,” Journal of Pain 8, no. 4 (2007): 343–348.CrossRefGoogle Scholar
Jones, K. R. Fink, R. M. Clark, L. Hutt, E. Vojir, C. P. Mellis, B. K., “Nursing Home Resident Barriers to Effective Pain Management: Why Nursing Home Residents May Not Seek Pain Medication,” Journal of the American Medical Directors Association 6, no. 1 (2005): 10–17; Ward, S. Goldberg, N. Miller-McCauley, V. Mueller, C. Nolan, A. Pawlik-Plank, D. Robbins, A. Stormoen, D. Weissman, D. E., “Patient-Related Barriers to Management of Cancer Pain,” Pain 52, no. 3 (1993): 319–324.CrossRefGoogle Scholar
Tait, R. C. Chibnall, J. T., “Observer Perceptions of Chronic Low Back Pain,” Journal of Applied Social Psychology 24, no. 5 (1994): 415–431.CrossRefGoogle Scholar
Nurmikko, T. J., “Anticonvulsants and Antiarrhythmics,” in Jensen, T. S. Wilson, P. R. Rice, A. S. C., eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): 251–260, at 252.Google Scholar
Martell, B. A. O'Connor, P. G. Kerns, R. D. Becker, W. C. Morales, K. H. Kosten, T. R. Fiellin, D. A., “Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction,” Annals of Internal Medicine 146, no. 2 (2007): 116–127.CrossRefGoogle Scholar
Fanciullo, G. J. Ball, P. A. Girault, G. Rose, R. J. Hanscom, B. Weinstein, J. N., “An Observational Study on the Prevalence and Pattern of Opioid Use in 25,479 Patients with Spine and Radicular Pain,” Spine 27, no. 2 (2002): 201–205, at 201; Rich, B. A., “Ethics of Opioid Analgesia for Chronic Noncancer Pain,” Pain: Clinical Updates 15, no. 9 (2007): 1–4.CrossRefGoogle Scholar
Webster, L. R. Fakata, K. L. Charapata, S. Fisher, R. MineHart, M., “Open-Label, Multicenter Study of Combined Intrathecal Morphine and Ziconitide: Addition of Morphine in Patients Receiving Ziconitide for Severe Chronic Pain,” Pain Medicine 9, no. 3 (2008): 282–290.CrossRefGoogle Scholar
Rog, D. J. Nurmikko, T. J. Friede, T. Young, C. A., “Randomized, Controlled Trial of Cannabis-based Medicine in Central Pain in Multiple Sclerosis,” Neurology 65, no. 6 (2005): 812–819; Ware, M. A. Doyle, C. R. Woods, R. Lynch, M. E. Clark, A. J., “Cannabis Use for Chronic Non-cancer Pain: Results of a Prospective Survey,” Pain 102, nos. 1–2 (2003): 211–216; Wilsey, B. Marcotte, T. Tsodikov, A. Millman, J. Bentley, H. Gouaux, B. Fishman, S., “A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain,” Journal of Pain 9, no. 6 (2008): 506–521.CrossRefGoogle Scholar
See Henderson, , supra note 10.Google Scholar
Dresser, R., “The Ubiquity and Utility of the Therapeutic Misconception,” Social Philosophy and Policy 19, no. 2 (2002): 271–294.CrossRefGoogle Scholar
See Tait, , supra note 29.Google Scholar
See Tait, Chibnall, , supra note 51.Google Scholar
See Chibnall, , supra note 28.Google Scholar
Wazana, A., “Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?” JAMA 283, no. 3 (2000): 373–380; Steinbrook, R., “Financial Support of Continuing Medical Education,” JAMA 299, no. 9 (2008): 1060–1062.CrossRefGoogle Scholar
Choudhry, N. K. Stelfox, H. T. Detsky, A. S., “Relationships between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry,” JAMA 287, no. 5 (2002): 612–617.CrossRefGoogle Scholar
Lemmons, T. Miller, P. B., “The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives,” Journal of Law, Medicine & Ethics 31, no. 3 (2003): 398–418.CrossRefGoogle Scholar
See Ross, , supra note 17.Google Scholar
See Chibnall, , supra note 28.Google Scholar
Beneke, M. Rasmus, W., “Clinical Global Impressions (ECDEU): Some Critical Comments,” Pharmacopsychiatry 25, no. 4 (1992): 171–176.CrossRefGoogle Scholar
See Chibnall, , supra note 28.Google Scholar
Rothman, K. J. Michels, K. B., “The Continuing Unethical Use of Placebo Controls,” New England Journal of Medicine 331, no. 6 (1994): 394–398; Khan, A. Warner, H. A. Brown, W. A., “Symptom Reduction and Suicide Risk in Patients Treated with Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database,” Archives of General Psychiatry 57, no. 4 (2000): 311–317.CrossRefGoogle Scholar
McQuay, H. J. Moore, R. A., “Placebo,” Postgraduate Medical Journal 81, no. 953 (2005): 155–160; Temple, R. Ellenberg, S. S., “Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments,” Annals of Internal Medicine 133, no. 6 (2000): 455–463.CrossRefGoogle Scholar
Dworkin, R. H. Katz, J. Gitlin, M. J., “Placebo Response in Clinical Trials of Depression and Its Implications for Research on Chronic Neuropathic Pain,” Neurology 65, no. 12, Supplement 4 (2005): S7–S19; Nagasako, E. M. Kalauokalani, D. A., “Ethical Aspects of Placebo Groups in Pain Trials,” Neurology 65, no. 12, Supplement 4 (2005): S59–S65.CrossRefGoogle Scholar
See McQuay, Moore, , supra note 70; Temple, Ellenberg, , supra note 70; Nagasako, Kalauokalani, , supra note 71.Google Scholar
See Dworkin, , supra note 71.Google Scholar
Erdal, K. J. Zautra, A. J., “Psychological Impact of Illness Downturns: A Comparison of New and Chronic Conditions,” Psychology and Aging 10, no. 4 (1995): 570–575.CrossRefGoogle Scholar
Luebbert, R. Tait, R. C. Chibnall, J. T. Deshields, T. L., “IRB member Judgments of Decisional Capacity, Coercion, and Risk in Medical and Psychiatric Studies,” Journal of Empirical Research in Human Research Ethics 3, no. 1 (2008): 15–24.CrossRefGoogle Scholar
See Rich, , supra notes 31 and 54; Tait, R. C. Miller, L., “The Multidisciplinary Treatment of Pain in Vulnerable Populations,” in Schatman, M. E. Campbell, A., eds., Chronic Pain Management: A Guidebook for Multidisciplinary Program Development (New York: Informa Healthcare, 2008): 129–150, at 129.Google Scholar
Sharpe, M. Mayou, R. Seagroatt, V. Surawy, C. Warwick, H., “Why Do Doctors Find Some Patients Difficult to Help?” Quarterly Journal of Medicine 87, no. 3 (1994): 187–193.Google Scholar
Gevirtz, C., “Imbalance and Inconsistency Continue in DEA Policy on Medical Use of Opioids,” Topics in Pain Management: Current Concepts and Treatment Strategies 21, no. 10 (2006): 6–7; see Rich, , supra note 54.Google Scholar
See Brennan, , supra note 8; Fishman, S. M., “Risk of the View through the Keyhole: There Is Much More to Physician Reactions to the DEA Than the Number of Formal Actions,” Pain Medicine 7, no. 4 (2006): 360–362; Jung, B. Reidenberg, M. M., “The Risk of Action by the Drug Enforcement Administration against Physicians Prescribing Opioids for Pain,” Pain Medicine 7, no. 4 (2006): 353–357.Google Scholar
Lin, J. J. Alfandre, D. Moore, C., “Physician Attitudes toward Opioid Prescribing for Patients with Persistent Non-cancer Pain,” Clinical Journal of Pain 23, no. 9 (2007): 799–803, at 802.CrossRefGoogle Scholar
See Brennan, , supra note 8; see Rich, , supra note 31.Google Scholar
Grisso, T. Appelbaum, P. S. Mulvey, E. P. Fletcher, K., “The MacArthur Treatment Competence Study, II: Measures of Abilities Related to Competence to Consent to Treatment,” Law and Human Behavior 19, no. 2 (1995): 127–148.CrossRefGoogle Scholar
See Luebbert, , supra note 75.Google Scholar
Redelmeier, D. A. Koehler, D. J. Liberman, V. Tversky, A., “Probability Judgment in Medicine: Discounting Unspecified Possibilities,” Medical Decision Making 15, no. 3 (1995): 227–230.CrossRefGoogle Scholar
See Brennan, , supra note 8.Google Scholar